Population
Patients with chronic kidney disease (CKD) and coronary artery disease
Design
Review
Authors
Loading...
Registry data should not guide revascularization choices in CKD; leaves open optimal CABG versus PCI strategy pending RCTs.
There is a critical need for randomized controlled trials to determine the optimal revascularization and secondary prevention strategies for patients with coronary artery disease and chronic kidney disease.
Edwards et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: